SARM
SR-9011
SaveA Rev-Erbα/β agonist closely related to SR9009, studied as a circadian-clock modulator and exercise mimetic in rodent models. Not a true SARM.
Quick verdict
Very similar profile to SR9009 with marginal published evidence. Entirely preclinical.
Evidence score
A rough internal score reflecting quantity, quality, and consistency of human evidence. Not a clinical recommendation.
What the research shows
Shares the Rev-Erb agonist mechanism with SR9009. Animal studies suggest effects on metabolism, exercise capacity, and circadian gene expression. No published human pharmacokinetic or efficacy data.
Benefits
- Modulates circadian metabolic pathways in animals
- Increased energy expenditure in rodent models
Dosage notes
No human dosing data available.
Side effects
- Unknown in humans
- Potential circadian disruption
Who should be cautious
No human safety data. Bioavailability in humans is unknown. Not approved for any use.
What this page cannot tell you
Oral bioavailability may be very poor in humans, similar to concerns with SR9009.
Leaderboard scores
- Energy20
- Weight loss15
Write a review
Sign in to write a review.